Pattern Bioscience, founded in 2016, is a in-vitro diagnostics company seeking to help combat the problem of antibiotic resistance. The company is developing a clinical microbiology platform based on its patented phenotypic single-cell technology with the goal of identifying pathogens and determining their antibiotic response without the need for traditional time-consuming culture steps. The platform is aiming to deliver more reliable diagnoses days faster than the current standard of care. Pattern Bioscience is headquartered in Austin, Texas.
View Enterprise Value for Pattern Bioscience.